Economic Evaluation Of Pertuzumab In Combination With Trastuzumab And Docetaxel In The Neoadjuvant Treatment Of Women With Her2-Positive, Locally Advanced, Inflammatory Or Early Breast Cancer In Portugal
AuthID
P-00M-PBP
P-00M-PBP